---
figid: PMC8350166__fncel-15-716747-g001
figtitle: 'PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis:
  A T Cell Perspective'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Mycobacterium tuberculosis
- gut metagenome
- Human immunodeficiency virus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC8350166
filename: fncel-15-716747-g001.jpg
figlink: /pmc/articles/PMC8350166/figure/F1/
number: F1
caption: The PD-1/PD-L1 axis in T cells differentiation and proliferation. PD-L1 (mainly
  expressed on APCs) binds to PD-1 on the surface of T cells and generates a co-inhibitory
  signal. The PD-1/PD-L1 interaction recruits SHP2 to block CD28-mediated activation
  of PI3K and AKT (i.e., reduce the levels of p-P13K and p-AKT). PD-L1 decreases the
  activity of mTOR by inhibiting p-AKT, and the mTOR pathway upregulates the expression
  of Foxp3 (↑) and downregulates the expression of p-STAT3 (↓), thereby inducing Treg/Th2
  differentiation and inhibits Th1/Th17 cell differentiation. PD-L1 can promote the
  expression of PTEN. PTEN dephosphorylates the inositol PIP3 on cell membranes to
  generate PIP2 and then antagonizes PI3K, which mediates cell growth, metabolism,
  proliferation, and survival signals. The PD-1/PD-L1 interaction inhibits Ras, which
  inhibits the activation of downstream MAPK/ERK signaling, leading to a reduction
  in ubiquitin ligase SCFSkp2-driven degradation of p27kip1. This process results
  in the accumulation of p27kip1, inhibition of Cdks, and further inhibition of T
  cell proliferation. Furthermore, PD-1 inhibits T cell proliferation by upregulating
  p27, p15, and Smad3, but inhibiting CDC25A.
papertitle: 'PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis:
  A T Cell Perspective.'
reftext: HaiXia Li, et al. Front Cell Neurosci. 2021;15:716747.
year: '2021'
doi: 10.3389/fncel.2021.716747
journal_title: Frontiers in Cellular Neuroscience
journal_nlm_ta: Front Cell Neurosci
publisher_name: Frontiers Media S.A.
keywords: experimental autoimmune encephalomyelitis | multiple sclerosis | T cells
  | programmed cell death ligand-1 | programmed cell death protein-1
automl_pathway: 0.9442858
figid_alias: PMC8350166__F1
figtype: Figure
redirect_from: /figures/PMC8350166__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8350166__fncel-15-716747-g001.html
  '@type': Dataset
  description: The PD-1/PD-L1 axis in T cells differentiation and proliferation. PD-L1
    (mainly expressed on APCs) binds to PD-1 on the surface of T cells and generates
    a co-inhibitory signal. The PD-1/PD-L1 interaction recruits SHP2 to block CD28-mediated
    activation of PI3K and AKT (i.e., reduce the levels of p-P13K and p-AKT). PD-L1
    decreases the activity of mTOR by inhibiting p-AKT, and the mTOR pathway upregulates
    the expression of Foxp3 (↑) and downregulates the expression of p-STAT3 (↓), thereby
    inducing Treg/Th2 differentiation and inhibits Th1/Th17 cell differentiation.
    PD-L1 can promote the expression of PTEN. PTEN dephosphorylates the inositol PIP3
    on cell membranes to generate PIP2 and then antagonizes PI3K, which mediates cell
    growth, metabolism, proliferation, and survival signals. The PD-1/PD-L1 interaction
    inhibits Ras, which inhibits the activation of downstream MAPK/ERK signaling,
    leading to a reduction in ubiquitin ligase SCFSkp2-driven degradation of p27kip1.
    This process results in the accumulation of p27kip1, inhibition of Cdks, and further
    inhibition of T cell proliferation. Furthermore, PD-1 inhibits T cell proliferation
    by upregulating p27, p15, and Smad3, but inhibiting CDC25A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pten
  - Cd80
  - Cd86
  - Cd28
  - Pik3r1
  - Akt1
  - Mtor
  - Cd274
  - Pdcd1
  - Ptpn11
  - Hand1
  - Nelfcd
  - Apc
  - Stat3
  - Hand2
  - ras
  - Hras
  - Kras
  - Rem1
  - Mdk
  - Ephb2
  - Mapk1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdc25c
  - Rasgrf1
  - PTEN
  - CD80
  - CD86
  - CD28
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - PTPN11
  - NELFCD
  - APC
  - PROC
  - STAT3
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - Pik3cg
  - Ephb1
  - Tmed7
  - ot
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tor
  - csw
  - TH1
  - Apc2
  - Axn
  - Fs(3)Apc
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - DCTN6-p27
  - dap
  - CG9588
  - Cdk4
  - twe
  - stg
  - Go
  - LanB2
  - anon-70Db
---
